Masaki Yasukawa

Masaki Yasukawa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Masaki Yasukawa sits on this spectrum.

Masaki Yasukawa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Masaki Yasukawa sits on this spectrum.

Overview

Best Publications

• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

  Fumihiko Ishikawa;Masaki Yasukawa;Bonnie Lyons;Shuro Yoshida

  1136
  Citations

• The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan

  Toru Takahashi;Ken Maeda;Tadaki Suzuki;Aki Ishido

  993
  Citations

• Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.

  Eiichi Ishii;Shouichi Ohga;Shinsaku Imashuku;Masaki Yasukawa

  579
  Citations

• HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide.

  Hideki Ohminami;Masaki Yasukawa;Shigeru Fujita

  458
  Citations

• Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.

  Leonard D. Shultz;Yoriko Saito;Yuho Najima;Satoshi Tanaka

  412
  Citations

• Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

  M. Tohyama;K. Hashimoto;M. Yasukawa;H. Kimura

  371
  Citations

• Severe Hypersensitivity Syndrome Due to Sulfasalazine Associated With Reactivation of Human Herpesvirus 6

  Mikiko Tohyama;Yoko Yahata;Masaki Yasukawa;Reiko Inagi

  341
  Citations

• Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.

  Masashi Kohno;Hitoshi Hasegawa;Atsushi Inoue;Masatake Muraoka

  280
  Citations

• Epstein–Barr virus-encoded poly(A)– RNA supports Burkitt’s lymphoma growth through interleukin-10 induction

  Norihiko Kitagawa;Miyuki Goto;Kimikazu Kurozumi;Seiji Maruo

  273
  Citations

• Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

  Sachiko Okamoto;Junichi Mineno;Hiroaki Ikeda;Hiroshi Fujiwara

  254
  Citations

• Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.

  M Yasukawa;J M Zarling

  209
  Citations

• A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.

  Shoichi Iriguchi;Shoichi Iriguchi;Yutaka Yasui;Yohei Kawai;Yohei Kawai;Suguru Arima

  195
  Citations

• Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.

  Masaki Yasukawa;Masaki Yasukawa;Hideki Ohminami;Hideki Ohminami;Junko Arai;Junko Arai;Yoshihito Kasahara;Yoshihito Kasahara

  189
  Citations

• Reinforce the antitumor activity of CD8+ T cells via glutamine restriction

  Shogo Nabe;Takeshi Yamada;Takeshi Yamada;Junpei Suzuki;Koji Toriyama

  184
  Citations

• HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection

  Aidan MacNamara;Aileen Rowan;Silva Hilburn;Ulrich Kadolsky

  181
  Citations

• Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

  Isao Tawara;Shinichi Kageyama;Yoshihiro Miyahara;Hiroshi Fujiwara

  181
  Citations

• Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.

  Junko Arai;Masaki Yasukawa;Hideki Ohminami;Miki Kakimoto

  171
  Citations

• Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions

  Eiichi Ishii;Ikuyo Ueda;Ryutaro Shirakawa;Ken Yamamoto

  167
  Citations

• Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

  Akihiro Tsuboi;Yoshihiro Oka;Keiko Udaka;Masaki Murakami

  164
  Citations

• Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.

  Atsutaka Minagawa;Atsutaka Minagawa;Atsutaka Minagawa;Toshiaki Yoshikawa;Masaki Yasukawa;Akitsu Hotta

  163
  Citations

• Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

  Yoshihiro Oka;Akihiro Tsuboi;Masaki Murakami;Manabu Hirai

  161
  Citations

• Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis.

  Koji Nagafuji;Atsushi Nonami;Takashi Kumano;Yoshikane Kikushige

  160
  Citations

• Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety

  Toshiki Ochi;Hiroshi Fujiwara;Sachiko Okamoto;Jun An

  159
  Citations